NCT04465734 2022-05-05A Clinical Study to Compare the Efficacy and Safety of HLX10 in Combination With HLX04 Versus Sorafenib as the First-line Treatment in Patients With Locally Advanced or Metastatic HCCShanghai Henlius BiotechPhase 3 Withdrawn